Mistaken fear of measles shot has ‚devastating‘ effect

 

Rochester, Minnesota, USA (August 30, 2011) – More than 150 cases of measles have been reported in the United States already this year and there have been similar outbreaks in Europe, a sign the disease is making an alarming comeback. The reappearance of the potentially deadly virus is the result of unfounded fears about a link between the measles shot and autism that have turned some parents against childhood vaccination, says Gregory Poland, M.D. (http://www.mayoclinic.org/bio/10966366.html), of Mayo Clinic. In the September issue of Mayo Clinic Proceedings (http://www.mayoclinicproceedings.com), Dr. Poland urges doctors to review extensive scientific research that has found no connection between the measles-mumps-rubella (MMR) vaccine and autism.

 

Fears about the MMR vaccine were sparked in 1998 by researcher Andrew Wakefield, M.D., in the British medical journal The Lancet (http://www.sciencedirect.com/science/journal/01406736). Dr. Wakefield’s study was later found fraudulent by the British General Medical Council and the paper was retracted. Even so, suspicions about the vaccine — as well as its additives such as thimerosal — have persisted, gaining steam with the public through celebrity advocates and widespread media coverage.

 

"A rising portion of the population is deciding not to immunize their children because of this controversy, and these children are now susceptible to the measles (http://www.mayoclinic.com/health/measles/DS00331) virus," says Dr. Poland, Mary Lowell Leary Professor of Medicine and director of the Mayo Clinic Vaccine Research Group.

 

"The results have been devastating," Dr. Poland says. "The campaign against the vaccine has caused great harm to public health across multiple nations, even though it has no scientific basis. There have been over 20 studies, spanning two decades, conducted in several countries. Not one has found scientific evidence of a connection between autism spectrum disorders and MMR vaccine."

 

Measles remains the most contagious infectious disease humans can get. It kills roughly three of every thousand people infected. Due to the vaccine’s effectiveness and successful immunization programs worldwide, indigenous cases of the disease had been eliminated in the U.S. and on track to be eradicated, similar to smallpox.

 

Dr. Poland recommends that doctors, patients, and the media become educated about the research on the research that already has been conducted and help rectify the misinformation. A major report released by the Institute of Medicine last week supports Dr. Poland’s claims of no connection between the MMR vaccine and autism (http://www.mayoclinic.com/health/autism/DS00348/DSECTION=causes).

 

"Just as significantly," he adds, "we need to direct appropriate and significant funds to determine what’s really causing autism in our children."

 

 

A peer-reviewed journal, Mayo Clinic Proceedings publishes original articles and reviews dealing with clinical and laboratory medicine, clinical research, basic science research and clinical epidemiology. Mayo Clinic Proceedings is published monthly by Mayo Foundation for Medical Education and Research as part of its commitment to the medical education of physicians. The journal has been published for more than 80 years and has a circulation of 130,000 nationally and internationally. Articles are available online at www.mayoclinicproceedings.com

 

 

About Mayo Clinic

 

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit www.mayoclinic.org/about

 


 

Mayo Clinic, 30.08.2011 (tB).

MEDICAL NEWS

New guidance to prevent the tragedy of unrecognized esophageal intubation
Overly restrictive salt intake may worsen outcomes for common form…
COVID-19 vaccines are estimated to have prevanented 20 million deaths…
Novel sleep education learning modules developed for nurse practitioners
Scientists discover how salt in tumours could help diagnose and…

SCHMERZ PAINCARE

Aktuelle Versorgungssituation der Opioidtherapie im Fokus
Individuelle Schmerztherapie mit Opioiden: Patienten im Mittelpunkt
Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…

DIABETES

Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Kaltplasma bei diabetischem Fußsyndrom wirkt via Wachstumsfaktoren
Typ-1-Diabetes: InRange – auf die Zeit im Zielbereich kommt es…

ERNÄHRUNG

Gesunde Ernährung: „Nicht das Salz und nicht das Fett verteufeln“
Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?

ONKOLOGIE

Nahrungsergänzungsmittel während der Krebstherapie: Es braucht mehr Bewusstsein für mögliche…
Fusobakterien und Krebs
Fortgeschrittenes Zervixkarzinom: Pembrolizumab verlängert Leben
Krebspatienten unter Immuntherapie: Kein Hinweis auf erhöhtes Risiko für schwere…
Aktuelle Kongressdaten zum metastasierten Mammakarzinom und kolorektalen Karzinom sowie Neues…

MULTIPLE SKLEROSE

Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…